Literature DB >> 8076935

Genetically polymorphic alpha-L-fucosidase (FUCA1) isozymes detected in blood plasma.

H Takeshita1, T Yasuda, D Nadano, R Iida, M Nakanaga, E Tenjo, K Sawazaki, K Kishi.   

Abstract

The main isozyme patterns of desialylated blood plasma or serum alpha-L-fucosidase (FUCA) were found to be almost identical to those of semen, urine, placental extracts, and leukocyte lysates, when detected by polyacrylamide gel isoelectric focusing, and activity staining using the fluorogenic substrate 4-methylumbelliferyl-alpha-L-fucopyranoside. Three phenotypes (1, 2-1, and 2) determined from plasma samples were identical to the phenotypes from urine and leukocyte lysates from the same individuals. A population study of plasma samples collected from 485 Japanese individuals indicated that the frequencies of the FUCA1*1 and FUCA1*2 alleles were 0.7505 and 0.2495, respectively. The mean plasma enzyme activities (+/- SD) of the three phenotypes were 318.8 +/- 116.7 nmol/ml per h for type 1, 268.0 +/- 108.3 nmol/ml per h for type 2-1, and 233.2 +/- 84.4 nmol/ml per h for type 2. The mean activities of types 1 and 2 suggest that, on average, the FUCA1*1 gene product in plasma has about 1.4 times the activity of FUCA1*2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8076935     DOI: 10.1007/bf00208274

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  Polymorphism of human alpha fucosidase.

Authors:  B M Turner; V S Turner; N G Beratis; K Hirschhorn
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

2.  Identification of a mutation in the structural alpha-L-fucosidase gene in fucosidosis.

Authors:  P J Willems; J K Darby; R A DiCioccio; P Nakashima; C Eng; K A Kretz; L L Cavalli-Sforza; E M Shooter; J S O'Brien
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

3.  Mucopolysaccharidosis by absence of alpha-fucosidase.

Authors:  F Van Hoof; H G Hers
Journal:  Lancet       Date:  1968-06-01       Impact factor: 79.321

4.  Further evidence of human alpha-L-fucosidase polymorphism.

Authors:  E M Beyer; G Y Wiederschain
Journal:  Clin Chim Acta       Date:  1982-08-18       Impact factor: 3.786

5.  Segregation analysis of alpha-L-fucosidase activity.

Authors:  L Iselius; J R Playfer; D A Evans
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

6.  Frequency of an allele for low activity of alpha-L-fucosidase in sera: possible increase in epithelial ovarian cancer patients.

Authors:  J J Barlow; R A DiCioccio; P H Dillard; L E Blumenson; K L Matta
Journal:  J Natl Cancer Inst       Date:  1981-11       Impact factor: 13.506

7.  Human serum alpha-L-fucosidase.

Authors:  J A Alhadeff; A J Janowsky
Journal:  Clin Chim Acta       Date:  1978-01-02       Impact factor: 3.786

8.  Plasma alpha-L-fucosidase activity and the risk of borderline epithelial ovarian tumors.

Authors:  B L Harlow; N S Weiss; E H Holmes
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

9.  Linkage of plasma alpha-L-fucosidase (FUCA2) and the plasminogen (PLG) system.

Authors:  H Eiberg; J Mohr; L S Nielsen
Journal:  Clin Genet       Date:  1984-07       Impact factor: 4.438

10.  Gene transfer by means of cell fusion. II. The mapping of 8 loci on human chromosome 1 by statistical analysis of gene assortment in somatic cell hybrids.

Authors:  S J Goss; H Harris
Journal:  J Cell Sci       Date:  1977-06       Impact factor: 5.285

View more
  1 in total

Review 1.  Dual role of fucosidase in cancers and its clinical potential.

Authors:  Jinxing Fu; Qing Guo; Yuan Feng; Peng Cheng; Anhua Wu
Journal:  J Cancer       Date:  2022-08-15       Impact factor: 4.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.